The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 14
- 14 new
- Median first-year cost
- $403,438
- $5,796,946 in all
- Institutions
- 13
- 14 contact PIs
- Patents
- 1
- from 1 funded project
Awards by fiscal year
Fiscal years 2014 to 2026.
Most frequent institutions
- NATIONAL JEWISH HEALTH2
- BRIGHAM AND WOMEN'S HOSPITAL1
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
- EMORY UNIVERSITY1
- FRED HUTCHINSON CANCER RESEARCH CENTER1
and 8 other institutions
Most frequent study sections
- Special Emphasis Panel (ZHL1 CSR-I (O1))8
- Special Emphasis Panel (ZHL1 CSR-I (F2))4
- Special Emphasis Panel (ZHL1 CSR-I (M1))2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2015 | Mucus Microstructure and Osmotic Pressure: Biomarkers for CB in COPD1R01HL125169-01A1 | Hanes, Justin S.Neptune, Enid R | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $449,417 | Study section ZHL1 |
| FY2015 | Cost Effectiveness Analysis of Stem Cell Transplant in Older MDS Patients1R01HL126589-01 | Ramsey, Scott D.Saber, Wael | FRED HUTCHINSON CANCER RESEARCH CENTER, WA | First-year cost $421,094 | Study section ZHL1 |
| FY2015 | SPLUNC1 in Severe Asthma1R01HL125128-01A1 | Chu, Hong WDi, Yuanpu Peter | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $405,084 | Study section ZHL1 |
| FY2015 | Genetics of Smoke-Altered LTA4H in COPD1R01HL126596-01 | Blalock, J EdwinCastaldi, PeterGaggar, Amit | UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL | First-year cost $401,792 | Study section ZHL1 |
| FY2015 | Epigenetic Regulation of Immunity in Alpha-1 Anti-trypsin Deficiency1R01HL126600-01 | Hamzeh, NabeelO'Connor, Brian P | NATIONAL JEWISH HEALTH, CO | First-year cost $393,891 | Study section ZHL1 |
| FY2015 | Blood Based Biomarkers of Injury and Outcome in the Prehospital TXA for TBI Trial1R01HL126585-01 | Rowell, Susan | OREGON HEALTH & SCIENCE UNIVERSITY, OR | First-year cost $388,992 | Study section ZHL1 |
| FY2015 | Nocturnal Rostral Fluid Shifts In Stroke Patients With Sleep Apnea1R01HL123379-01A1 | Brown, Devin LLisabeth, Lynda D | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | First-year cost $377,615 | Study section ZHL1 |
| FY2015 | Contribution of neutrophils to early airway disease in cystic fibrosis children1R01HL126603-01 | Tirouvanziam, Rabindra Marie-Jean | EMORY UNIVERSITY, GA | First-year cost $350,489 | Study section ZHL1 |
| FY2014 | CIAO-ISCHEMIA - Resubmission - 11R01HL119153-01A1 | Reynolds, Harmony R. | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | First-year cost $490,220 | Study section ZHL1 |
| FY2014 | Effect of Low Dose Methotrexate on Arterial Inflammation in HIV1R01HL122177-01A1 | Tawakol, Ahmed A | MASSACHUSETTS GENERAL HOSPITAL, MA | First-year cost $451,313 | Study section ZHL1 |
| FY2014 | Anti-inflammatory Therapy with Low Dose Methotrexate for Reduction of PAD1R01HL122158-01A1 | Pradhan, Aruna Das | BRIGHAM AND WOMEN'S HOSPITAL, MA | First-year cost $442,291 | Study section ZHL1 |
| FY2014 | Effect of Blood Transfusion Practices on Cerebral and Somatic Oximetry1R01HL122167-01A1 | Chock, Valerie | STANFORD UNIVERSITY, CA | First-year cost $428,508 | Study section ZHL1 |
| FY2014 | PTSD, Medication Adherence, and Prognosis after Acute Coronary Syndromes1R01HL123368-01 | Kronish, Ian Matthew | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $399,990 | Study section ZHL1 |
| FY2014 | Improved Prediction of Response to Asthma Medication Using Small Molecules1R01HL123385-01A1 | Reisdorph, Nichole A | NATIONAL JEWISH HEALTH, CO | First-year cost $396,250 | Study section ZHL1 |
Patents from its funded projects
1 patent names 1 of the 14 funded projects.
- US 11,286,287 (opens the patent at USPTO, a PDF, in a new tab)NOVEL ANTIMICROBIAL AND ANTI-CANCER THERAPYGranted March 29, 2022 to University of Pittsburgh—Of the Commonwealth System of Higher EducationR01HL125128 · UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA
Each number opens the patent at USPTO, beside the project NIH ties it to and that project's institution. NIH ties a patent to a project, not to a year of its funding, and says its list is incomplete. The grant date and the owners are USPTO's: the organizations the patent names as assignees on the day it was granted. Source: United States Patent and Trademark Office, www.uspto.gov, which does not endorse ScienceDex.
Data: Grants.gov's daily extract and NIH's notice pages, award files and patents file, in ScienceGraph release conductgrants-2026-11-15-0.3.4. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.